| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10163208 | Pediatria Polska | 2011 | 4 Pages |
Abstract
Rituximab seems to be a safe medication, which not always permit the remission of NS. The efficacy and indication of rituximab need further evaluation.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Anna MedyÅska, Katarzyna KiliÅ-PstrusiÅska, Magdalena NaleÅniak-Kubicka, Anna Jakubowska, Danuta ZwoliÅska,